survodutide peptide vs retatrutide 🎙️ NEW EPISODE: Retatrutide—The Triple Agonist *Not licensed* Will this replace the current GLP-1 in the market., This triple receptor agonist (GIP/GLP-1/glucagon) is showing unprecedented results in Triple hormone receptor agonist retatrutide
Description
Whether that premium is worth it depends on your risk tolerance and whether you value having a prescriber monitor your progress and side effects
What to actually do about it The strongest evidence for what changes the body composition equation comes from a randomized, head-to-head, placebo-controlled trial published by Lundgren and colleagues in NEJM in 2021
2013;36:e28
Review of Cardiovascular Outcomes Trials of Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists
Meals high in fat often lead to immediate consequences, so the treatment can reinforce behaviour change in a very direct way
Local shop expands into weight-loss boom with new GLP-1 clinic Published at Getting your Trinity Audio player ready
